Cancer News and Research

Latest Cancer News and Research

New clinical trial launched to test potential drug that could help immune system combat cancer

Cancer Research UK's Centre for Drug Development, in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours.

24 Feb 2016

MR Solutions introduces new 3D in vivo confocal microscope for preclinical research

MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs.

From MR Solutions 24 Feb 2016

Ohio State researchers working on new way to treat drug-resistant cancer

Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of--only it's not a Trojan horse, but DNA that hides the invading force.

24 Feb 2016

New study shows beneficial effects of fish consumption during pregnancy

A new study supports the theory that the detrimental effects of low-level exposure to mercury may be outweighed by the beneficial effects of fish consumption.

24 Feb 2016

Novel unit can significantly speed access to specialized care for critically ill patients

A novel unit to care for critically ill patients significantly speeds access to specialized care, according to a new study by physician scientists at the University of Maryland School of Medicine and the University of Maryland Medical Center.

24 Feb 2016

New study identifies cell communication mechanism

The cells of an organism interact not only with each other but with the extracellular matrix that surrounds them. Increasing evidence is unveiling the relevance of this structure--which is secreted by the cells themselves-- for the correct function of the organism and also for the development of various diseases.

24 Feb 2016

Maryland Proton Treatment Center completes first patient treatment with Varian ProBeam system

Varian Medical Systems, today announced the Maryland Proton Treatment Center successfully completed its first patient treatment with the Varian ProBeam system. The MPTC at the University of Maryland BioPark in West Baltimore houses five treatment rooms and is the first in the Eastern US to offer image-guided intensity-modulated proton therapy (IMPT) with a ProBeam system.

24 Feb 2016

New TAU study suggests potential therapeutic pathway to keep osteosarcoma lesions dormant

Osteosarcoma is a cancer that develops in the bones of children and adolescents. It is one of the most aggressive cancers, with only a 15 per cent, five-year survival rate when diagnosed in an advanced metastatic stage. There are approximately 800 new cases diagnosed each year in the US, and no viable treatments.

23 Feb 2016

UCLA researchers pioneer more effective approach to improve cancer treatment

Despite a growing interest in developing non-invasive methods to identify rare cancer cells or cancer cell DNA in blood, current techniques remain complicated and often prohibitively expensive. Now, UCLA researchers have pioneered a more effective approach to these "liquid biopsies" that has the potential to offer a streamlined and low-cost solution for people with the disease.

23 Feb 2016

Researchers devise new approach to improve current T-cell therapy methods

T-cell therapy, a form of immunotherapy that uses a patient's own immune cells to attack their cancer, has been making waves recently. The "living" therapy involves engineering the patient's T cells in the laboratory to carry new proteins that guide the immune cells directly to tumor cells, allowing the engineered T cells to attack and kill the cancer.

23 Feb 2016

UAB researchers use Malvern’s NanoSight NS300 system to figure out role of exosomes in disease transmission

Data measured using the NanoSight NS300 from Malvern Instruments is providing new insights into the role of exosomes in diseases such as cancer, arthritis, Alzheimer’s disease and cystic fibrosis, in pioneering research at the University of Alabama - Birmingham (UAB).

23 Feb 2016

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication expanding the use of IBRANCE (palbociclib) 125mg capsules, Pfizer’s metastatic breast cancer therapy.

23 Feb 2016

Researchers Pinpoint Potential Enzyme For T-Cell Leukemia Treatment

For the first time, researchers at Boston University have shown that T-cell leukemia cells use a particular cycle, called the TCA or Kreb cycle, to support their growth and survival.

23 Feb 2016

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson's disease.

23 Feb 2016

Hiroshima University researchers identify new class of cancer-causing genetic variations

Researchers at Hiroshima University have opened the door to finding a new class of cancer-causing genetic variations.

23 Feb 2016

UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

Heidi M. Mansour, PhD, assistant professor in the University of Arizona College of Pharmacy, is working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases.

23 Feb 2016

SIFT 4G software can lead to faster genome analysis

An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS) and the Bioinformatics Institute (BII), have developed SIFT 4G (SIFT for Genomes) - a software that can lead to faster genome analysis.

23 Feb 2016

Consuming dried plums can protect from radiation-induced bone loss

Dr. Nancy Turner, a Texas A&M AgriLife Research scientist in College Station, was one of a team of researchers who recently studied different interventions to protect from radiation-induced bone loss.

23 Feb 2016

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.

23 Feb 2016

BCRF expands research program with new collaborative breast cancer funding model

The Breast Cancer Research Foundation announced the expansion of its research program with a new collaborative breast cancer funding model—the BCRF Investigator-Initiated Drug Research Program—that will help broaden and accelerate clinical research on treatment strategies for people with breast cancer.

22 Feb 2016

Cancer News and Research

Latest Cancer News and Research

New clinical trial launched to test potential drug that could help immune system combat cancer

MR Solutions introduces new 3D in vivo confocal microscope for preclinical research

Ohio State researchers working on new way to treat drug-resistant cancer

New study shows beneficial effects of fish consumption during pregnancy

Novel unit can significantly speed access to specialized care for critically ill patients

New study identifies cell communication mechanism

Maryland Proton Treatment Center completes first patient treatment with Varian ProBeam system

New TAU study suggests potential therapeutic pathway to keep osteosarcoma lesions dormant

UCLA researchers pioneer more effective approach to improve cancer treatment

Researchers devise new approach to improve current T-cell therapy methods

UAB researchers use Malvern’s NanoSight NS300 system to figure out role of exosomes in disease transmission

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Researchers Pinpoint Potential Enzyme For T-Cell Leukemia Treatment

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

Hiroshima University researchers identify new class of cancer-causing genetic variations

UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

SIFT 4G software can lead to faster genome analysis

Consuming dried plums can protect from radiation-induced bone loss

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

BCRF expands research program with new collaborative breast cancer funding model

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in